Affiliation:
1. Department of Chemistry, Tshwane University of Technology, 175 Nelson Mandela Drive, Private Bag X680, Pretoria 0001, South Africa
2. Department of Chemistry, United Arab Emirates University, Al-Ain 15551, United Arab Emirates
Abstract
Fatalities caused by infectious diseases (i.e., diseases caused by parasite, bacteria, and viruses) have become reinstated as a major public health threat globally. Factors such as antimicrobial resistance and viral complications are the key contributors to the death numbers. As a result, new compounds with structural diversity classes are critical for controlling the virulence of pathogens that are multi-drug resistant. Derivatization of bio-active organic molecules with organometallic synthons is a promising strategy for modifying the inherent and enhanced properties of biomolecules. Due to their redox chemistry, bioactivity, and structural diversity, organometallic moieties make excellent candidates for lead structures in drug development. Furthermore, organometallic compounds open an array of potential in therapy that existing organic molecules lack, i.e., their ability to fulfill drug availability and resolve the frequent succumbing of organic molecules to drug resistance. Additionally, metal complexes have the potential towards metal-specific modes of action, preventing bacteria from developing resistance mechanisms. This review’s main contribution is to provide a thorough account of the biological efficacy (in vitro and in vitro) of metal-based complexes against infectious diseases. This resource can also be utilized in conjunction with corresponding journals on metal-based complexes investigated against infectious diseases.
Funder
National Research Foundation
Tshwane University of Technology
Subject
Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science
Reference59 articles.
1. Emerging infectious diseases: A proactive approach;Bloom;Proc. Natl. Acad. Sci. USA,2017
2. Infectious disease threats in the twenty-first century: Strengthening the global response;Bloom;Front. Immunol.,2019
3. The challenge of emerging and re-emerging infectious diseases;Morens;Nature,2004
4. Utility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses;Sperk;J. Proteome Res.,2020
5. WHO (2021). The True Death Toll of COVID-19: Estimating Global Excess Mortality, World Health Organisation. Available online: https://www.who.int/data/stories/the-true-death-toll-of-covid-19-estimating-global-excess-mortality.